Baclofen pumps do not increase risk of complications following spinal fusion.
Baclofen
Cerebral palsy
Complications
Scoliosis
Spinal fusion
Journal
Spine deformity
ISSN: 2212-1358
Titre abrégé: Spine Deform
Pays: England
ID NLM: 101603979
Informations de publication
Date de publication:
25 Nov 2023
25 Nov 2023
Historique:
received:
02
08
2023
accepted:
21
10
2023
medline:
26
11
2023
pubmed:
26
11
2023
entrez:
25
11
2023
Statut:
aheadofprint
Résumé
To assess the complication risks associated with intrathecal baclofen (ITB) pumps in cerebral palsy (CP) patients undergoing posterior spinal fusion (PSF) and to determine if timing of pump implantation before or during PSF impacts the risk of complications. A prospectively collected multicenter database was retrospectively reviewed to identify CP patients undergoing PSF from 2008 to 2023. Patients were divided into 2 cohorts: those with an ITB pump (ITB cohort) and those without (non-ITB cohort). The ITB cohort was further categorized by placement of the pump prior to or during PSF. Cohorts were then compared in terms of postoperative complications, perioperative complications, and need for revision surgery. Four hundred six patients (ITB n = 79 [53 prior to, 26 during PSF], non-ITB n = 326) were included in this analysis. At an average follow-up of 4.0 years (range 2-10 years), there were no significant differences between the ITB and non-ITB cohorts in the rate of perioperative complications (5.0% vs 6.5%, p = 0.80), revision surgeries (2.5% vs 4.6%, p = 0.54), or any complication type, regardless of whether pumps were placed prior to or during PSF, aside from longer surgical times in the latter group. Complication rates are similar for ITBs placed prior to and during PSF. Patients with spastic CP may safely be treated with ITB pumps without increased risks of complication or further reoperation/revision following PSF. Level III.
Identifiants
pubmed: 38006455
doi: 10.1007/s43390-023-00786-8
pii: 10.1007/s43390-023-00786-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Scoliosis Research Society.
Références
Gilmartin R, Bruce D, Storrs BB, Abbott R, Krach L, Ward J, Bloom K, Brooks WH, Johnson DL, Madsen JR, McLaughlin JF, Nadell J (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 15:71–77. https://doi.org/10.1177/088307380001500201
doi: 10.1177/088307380001500201
pubmed: 10695888
Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen for spasticity in cerebral palsy. JAMA 265:1418–1422. https://doi.org/10.1097/00002060-200011000-00010
doi: 10.1097/00002060-200011000-00010
pubmed: 1999883
Stempien L, Tsai T (2000) Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 79:536. https://doi.org/10.1097/00002060-200011000-00010
doi: 10.1097/00002060-200011000-00010
pubmed: 11083304
Borowski A, Littleton AG, Borkhuu B, Presedo A, Shah S, Dabney KW, Lyons S, McMannus M, Miller F (2010) Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop 30:76. https://doi.org/10.1097/BPO.0b013e3181c6b257
doi: 10.1097/BPO.0b013e3181c6b257
pubmed: 20032747
Dickey MP, Rice M, Kinnett DG, Lambert R, Donauer S, Gerber MA, Staat MA (2013) Infectious complications of intrathecal baclofen pump devices in a pediatric population. Pediatr Infect Dis J 32:715. https://doi.org/10.1097/INF.0b013e318287f02a
doi: 10.1097/INF.0b013e318287f02a
pubmed: 23429557
Walter M, Altermatt S, Furrer C, Meyer-Heim A (2014) Intrathecal baclofen therapy in children with severe spasticity: outcome and complications. Dev Neurorehabil 17:368–374. https://doi.org/10.3109/17518423.2013.827256
doi: 10.3109/17518423.2013.827256
pubmed: 23977869
Jones-Quaidoo SM, Yang S, Arlet V (2010) Surgical management of spinal deformities in cerebral palsy. A review. J Neurosurg Spine 13:672–685. https://doi.org/10.3171/2010.5.SPINE09669
doi: 10.3171/2010.5.SPINE09669
pubmed: 21121743
Scannell B, Yaszay B (2015) Scoliosis, spinal fusion, and intrathecal baclofen pump implantation. Phys Med Rehabil Clin N Am 26:79–88. https://doi.org/10.1016/j.pmr.2014.09.003
doi: 10.1016/j.pmr.2014.09.003
pubmed: 25479781
Reames DL, Smith JS, Fu K-MG, Polly DWJ, Ames CP, Berven SH, Perra JH, Glassman SD, McCarthy RE, Knapp RDJ, Heary R, Shaffrey CI, Committee SRSM and M (2011) Complications in the surgical treatment of 19,360 cases of pediatric scoliosis: a review of the scoliosis research society morbidity and mortality database. Spine 36:1484. https://doi.org/10.1097/BRS.0b013e3181f3a326
doi: 10.1097/BRS.0b013e3181f3a326
pubmed: 21037528
Sponseller PD, Shah SA, Abel MF, Newton PO, Letko L, Marks M (2010) Infection rate after spine surgery in cerebral palsy is high and impairs results: multicenter analysis of risk factors and treatment. Clin Orthop Relat Res 468:711. https://doi.org/10.1007/s11999-009-0933-4
doi: 10.1007/s11999-009-0933-4
pubmed: 19543779
Yaszay B, Bartley CE, Sponseller PD, Abel M, Cahill PJ, Shah SA, Miyanji F, Samdani AF, Daquino C, Newton PO (2020) Major complications following surgical correction of spine deformity in 257 patients with cerebral palsy. Spine Deform 8:1305–1312. https://doi.org/10.1007/s43390-020-00165-7
doi: 10.1007/s43390-020-00165-7
pubmed: 32720268
pmcid: 7384279
Borowski A, Shah SA, Littleton AG, Dabney KW, Miller F (2008) Baclofen pump implantation and spinal fusion in children: techniques and complications. Spine 33:1995. https://doi.org/10.1097/BRS.0b013e31817bab42
doi: 10.1097/BRS.0b013e31817bab42
pubmed: 18708932
Caird MS, Palanca AA, Garton H, Hensinger RN, Ayyangar RN, Drongowski A, Farley FA (2008) Outcomes of posterior spinal fusion and instrumentation in patients with continuous intrathecal baclofen infusion pumps. Spine 33:E94. https://doi.org/10.1097/BRS.0b013e3181642aae
doi: 10.1097/BRS.0b013e3181642aae
pubmed: 18277862
Yaszay B, Scannell BP, Bomar JD, Sponseller PD, Shah SA, Asghar J, Samdani AF, Bastrom TP, Newton PO, Group HS (2015) Although inconvenient, baclofen pumps do not complicate scoliosis surgery in patients with cerebral palsy. Spine 40:E504. https://doi.org/10.1097/BRS.0000000000000811
doi: 10.1097/BRS.0000000000000811
pubmed: 25868105
Lins LAB, Nechyporenko AV, Halanski MA, Hetzel SJ, Noonan KJ (2020) Does an intrathecal baclofen pump impact scoliosis progression and complicate posterior spine fusion in patients with cerebral palsy? Spine Deform 8:115–121. https://doi.org/10.1007/s43390-020-00034-3
doi: 10.1007/s43390-020-00034-3
pubmed: 31981152
Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B (1997) Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 39:214–223. https://doi.org/10.1111/j.1469-8749.1997.tb07414.x
doi: 10.1111/j.1469-8749.1997.tb07414.x
pubmed: 9183258
Bonouvrié LA, Lagendijk KE, Beckerman H, Slot KM, van de Pol LA, Buizer AI (2022) Surgical complications of intrathecal baclofen in children: a single centre, 20-year retrospective cohort study. Eur J Paediatr Neurol 37:94–97. https://doi.org/10.1016/j.ejpn.2022.02.002
doi: 10.1016/j.ejpn.2022.02.002
pubmed: 35180559
Motta F, Antonello CE (2014) Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience: clinical article. J Neurosurg Pediatr 13:301–306. https://doi.org/10.3171/2013.11.PEDS13253
doi: 10.3171/2013.11.PEDS13253
pubmed: 24404968
Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL (2001) Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery 49:753. https://doi.org/10.1097/00006123-200109000-00045
doi: 10.1097/00006123-200109000-00045
pubmed: 11523691
Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML (2003) Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 39:1–6. https://doi.org/10.1159/000070870
doi: 10.1159/000070870
pubmed: 12784068
Murphy NA, Irwin MCN, Hoff C (2002) Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil 83:1721–1725. https://doi.org/10.1053/apmr.2002.36068
doi: 10.1053/apmr.2002.36068
pubmed: 12474176
Lipton GE, Miller F, Dabney KW, Altiok H, Bachrach SJ (1999) Factors predicting postoperative complications following spinal fusions in children with cerebral palsy. J Spinal Disord 12:197–205
pubmed: 10382772
Xu AL, Marrache M, Hardesty CK, Groves ML, Erickson MA, Murphy RF, Thompson GH, Sponseller PD (2022) Baclofen pump use: complications after growth-friendly instrumentation for early-onset scoliosis. J Pediatr Orthop 42:77. https://doi.org/10.1097/BPO.0000000000002035
doi: 10.1097/BPO.0000000000002035
pubmed: 34882588
Imerci A, Rogers KJ, Miller F, Sees JP (2020) Evaluation of risk factors for cerebrospinal leakage in pediatric patients with cerebral palsy treated with intrathecal baclofen. J Pediatr Orthop 40:e522. https://doi.org/10.1097/BPO.0000000000001472
doi: 10.1097/BPO.0000000000001472
pubmed: 32501926
Segal LS, Wallach DM, Kanev PM (2005) Potential complications of posterior spine fusion and instrumentation in patients with cerebral palsy treated with intrathecal baclofen infusion. Spine (Phila Pa 1976) 30:E219-224. https://doi.org/10.1097/01.brs.0000158869.90908.f8
doi: 10.1097/01.brs.0000158869.90908.f8
pubmed: 15834321
Senaran H, Shah SA, Presedo A, Dabney KW, Glutting JW, Miller F (2007) The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. Spine 32:2348. https://doi.org/10.1097/BRS.0b013e3181557252
doi: 10.1097/BRS.0b013e3181557252
pubmed: 17906577
Rushton PRP, Nasto LA, Aujla RK, Ammar A, Grevitt MP, Vloeberghs MH (2017) Intrathecal baclofen pumps do not accelerate progression of scoliosis in quadriplegic spastic cerebral palsy. Eur Spine J 26:1652–1657. https://doi.org/10.1007/s00586-016-4598-x
doi: 10.1007/s00586-016-4598-x
pubmed: 27154169
Shilt JS, Lai LP, Cabrera MN, Frino J, Smith BP (2008) The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. J Pediatr Orthop 28:684. https://doi.org/10.1097/BPO.0b013e318183d591
doi: 10.1097/BPO.0b013e318183d591
pubmed: 18724209